Purpose: To demonstrate the accuracy and sensitivity of Representational Oligonucleotide Microarray Analysis (ROMA) to describe copy number changes in patients with chromosomal abnormalities. Methods: ROMA was performed using BglII digested DNA from two cases with cytogenetically detected deletions and one case with an unbalanced terminal rearrangement detected only by subtelomeric FISH. Hybridization was to an 85,000-probe oligonucleotide microarray, providing an average resolution of 35 kb. FISH was used to confirm some of the ROMA findings. Results: By ROMA, a del(13)(q14.3q21.2) was shown to be noncontiguous, with deletions extending from 53.08 to 61.40 Mb and from 72.88 to 74.83 Mb. The 10-Mb deletion contained only six known genes. FISH confirmed the noncontiguous nature of the deletion, as well as a small amplification in 6q that was also found in the patient's mother. A del(4)(q12q21.2) was found by ROMA to be 23 Mb in length, from 58.8 to 81.9 Mb on chromosome 4, in agreement with the cytogenetically assigned breakpoints. ROMA showed that an unbalanced "subtelomeric" rearrangement involved a 6-Mb deletion of 22q and an 8-Mb duplication of 16q. Conclusions:
The resolution of cytogenetic analysis has been continually improved through the introduction of new techniques, such as high-resolution banding, FISH analysis for microdeletions and subtelomeric rearrangements, multichromosome painting by SKY or M-FISH, and chromosomal comparative genomic hybridization (CGH). Most recently, CGH on genomic microarrays has permitted high-resolution chromosome scanning to define copy number variation in the genome. The usual methods involve BAC micoarrays, which can be selected to provide varying levels of resolution. A complete tiling microarray across the complete genome has been reported, 1 with a theoretical resolution of 100 to 200 Kb, but clinical application of whole genome scanning has been largely limited to arrays with Ն 1-Mb resolution. One recent study 2 reports de novo chromosomal deletions or duplications in 7 of 50 patients with learning disability and dysmorphic features, suggesting that such rearrangements may be quite frequent as causes of congenital abnormalities.
Representational Oligonucleotide Microarray Analysis (ROMA) is a new approach that allows very high resolution scanning for copy number variation across the whole genome. 3 In brief, this method involves the following: (1) digestion of the subject's DNA with an enzyme such as BglII, followed by amplification by adaptor-mediated PCR, resulting in a "representation" of the genome; (2) design of a microarray using probes hybridizing with short 200 to 1200 bp restriction fragments and preselected for good hybridization performance. 4 The microarrays used in this study consist of 85,000 probes (85K), with a resolution of about 35 kb; (3) CGH to the microarray of representations from test and control DNA; and (4) statistical analysis using a Hidden Markov model 5 to determine segmental deletions or duplications.
To date, ROMA has been used to define copy number changes in tumors 3 and to reveal the extent of the large-scale copy number polymorphism in the human genome. 5 In this report, we present the first use of ROMA on three children with known constitutional chromosome abnormalities, which serves not only to validate the method, but also to illustrate the extraordinary precision with which we can now define chromosomal imbalances. Not only did ROMA reveal unexpected complexity, but also the precise definition of the abnormalities was useful in interpreting the clinical findings and providing information to the parents.
PATIENT MATERIAL AND METHODS

Clinical information
Patient 1
Patient 1 is the third child of a G4P4 32-year-old mother and a 33-year-old father. The proband's pregnancy and delivery were uncomplicated, and his birth weight was 7 lb 9 oz. He was initially evaluated at the age of 3 months because of failure to thrive, hypotonia, and associated feeding difficulties. MRI of brain with spectroscopy and echocardiogram were normal. Renal ultrasound demonstrated a small left kidney. Extensive metabolic and genetic evaluations revealed only the karyotypic abnormality discussed below.
The child was seen at Columbia University Medical Center for the first time at age 2 years and 2 months. At that time, the height and weight were in the 25th percentile. The mother reported delayed major motor milestones, including rolling over at 4 months, sitting without support at 8 months, and walking at 22 months. He had been receiving regular physical therapy for delay in gross motor skills. He spoke in short sentences and understood complex commands. There were no facial dysmorphisms besides slightly cupped ears and no medical problems except for severe eczema.
At three years, development status is normal, except for mild delay in gross motor skills and coordination. The child converses in full sentences, retells stories, knows colors, and repeats nursery rhymes. Height and weight remain in the 25th percentile.
Patient 2
Patient 2 was a 19-month-old male at the time of initial evaluation. He was the product of a 37-week gestation, born via C-section for failure to progress to a 40-year-old G1P0 woman. An amniocentesis performed at another institution for advanced maternal age was reported as a normal 46 XY karyotype. Birth weight was 6 lb 2 oz (10%), and length was 18 inches (Ͻ 5%). His neonatal course was complicated by vomiting associated with a large anterior fontanel, which prompted a MRI that demonstrated a left caudate infarct of prenatal origin. He had persistent failure to thrive with height and weight less than the third percentiles for the first 18 months of life, associated with gastroesophageal reflux, constipation, and recurrent postprandial hypoglycemia that ultimately required gastrostomy tube placement and continuous feeds to avoid hypoglycemia. Several months after starting his continuous feeds, his weight normalized to the 25th percentile, and his length normalized to the 10th percentile. There was no evidence of hyperinsulinism, growth hormone deficiency, adrenal insufficiency, fatty acid oxidation disorder, organic acidemia, or glycogen storage disorder. He has renal tubular acidosis and renal calculi and a history of recurrent otitis media and pneumonia. He is hypotonic and developmentally delayed, with a developmental quotient of 52. His mildly dysmorphic features include a triangular face, delayed closing of the anterior fontanel, frontal bossing with a wide forehead, deeply set eyes, highly arched palate, and micrognathia.
Patient 3
Patient 3 was the 7 lb 12 oz product of a 38-week pregnancy and normal delivery. At 28 months, she was evaluated and was noted to have significant developmental delay, microcephaly, hypotonia, joint laxity at the wrist and fingers, contractures of the knees, and dysmorphic features including bilateral epicanthal folds, low set posteriorly rotated ears, wide upper gums and a narrow high-arched palate, widely spaced nipples, and wrinkling of the skin on the hands, palms, and soles of the feet. MRI of the brain demonstrated an absent corpus callosum, and hydronephrosis was observed on the abdominal ultrasound. At 4 years, 9 months, the patient has no verbal language and is severely developmentally delayed.
Cytogenetic analysis and FISH
Cytogenetic analysis was performed from peripheral blood samples using G-banding at the 550 level of resolution. FISH analysis for subtelomeric regions used the ToTelVysion probe set (Vysis, Inc. Downer's Grove, IL) and the method recommended by the manufacturer. SKY analysis on Patient 1 used the Applied Spectral Imaging Inc (Carlsbad, CA) system.
To validate the genome scan, we performed FISH analysis using BAC/PAC clones from the deleted, nondeleted, and amplified regions to metaphase chromosomes and interphase nuclei of Patient 1 and his parents. BAC clones mapping to the appropriate regions were selected from the UCSC Genome Browser (http://genome.ucsc.edu/) and purchased from the BacPac Resources Centre (http://www.chori.org/bacpac/). Single BAC colonies were inoculated in LB/chloramphenicol and the PAC colonies were inoculated in LB/kanamycin and cultured overnight, followed by DNA preparation using the Qiagen Large Construct DNA preparation procedure. One microgram of the cloned DNA was labeled using either Spectrum Red or Spectrum Green dUTP by nick translation labeling kit (Vysis, Downer's Grove, IL). For cohybridization of neighboring BAC clones, the probes were differentially labeled using either spectrum red or green. FISH was performed according to the manufacturer's protocol (Vysis, Downer's Grove, IL).
Genome scan for copy number change using ROMA Analysis was blind to the karyotypic findings. ROMA was performed using an 85k chip with approximately 35-kb resolution across the genome, as previously described. 3 In brief, DNA was isolated from peripheral blood lymphocytes using a FlexiGene DNA kit (Qiagen, CA) according to the manufacturer's instructions. BglII representations were prepared from the patient DNA and the normal male reference DNA. After BglII digestion, adapters were ligated and the resulting product used as a template for a PCR reaction. The resulting genomic representation was hybridized to the 85k chip (NimbleGen Systems, Reykjavic, Iceland) and scanned by an Axon GenePix 4000A scanner. Segmental changes in copy number were identified using a Hidden Markov Model predictor. 5 The protocol for this study was approved by the Columbia Institutional Review Board and informed consent for the ROMA analysis was obtained from the parents of all the patients.
RESULTS
Cytogenetic analysis
Patient 1
At 3 months, the karyotype was found to have an apparently balanced translocation between the long arms of chromosome 3 and 10 ( Fig. 1a) , as well as an interstitial deletion of chromosome 13 with breakpoints in q14.3 and q21.2 (Fig. 1b) : the complete karyotype was 46,XY,t(3;10)(q23;q11.2),del(13) (q14.3q21.2). Parental chromosomes were normal. The G-banded karyotype was later confirmed by FISH using the SKY technique, which demonstrated the known translocation between chromosome 3 and 10 but no more complex rearrangements. FISH using the LSI 13 probe (Vysis, Inc.) showed that the RB1 locus was not deleted.
Patient 2
Repeat of the karyotype at Columbia showed a large deletion of proximal chromosome 4q, 46,XY,del(4)(q12q21.2) (Fig. 2) .
Parental chromosomes were normal. FISH with chromosome 4 paint did not reveal any additional abnormalities.
Patient 3
The karyotype by G-banding was normal 46,XX. FISH using the ToTelVysion probe set (Vysis, Inc) revealed an unbalanced terminal rearrangement, with an additional copy of the 16q subtelomeric probe on the end of the q arm of a small acrocentric chromosome and a deleted copy of the 22q subtelomeric probe. Parental chromosome analysis using subtelomeric probes showed that the father was a carrier of a balanced translocation: 46,XY,t(16;
ROMA analysis
All cytogenetically visible chromosomal imbalances were also detected by ROMA. These abnormal lesions were easily distinguishable from normal copy number polymorphism (CNP) 5 based on their size. The smallest aberration detected was approximately 2 Mb in size and involved 68 probes, which is substantially larger than the average length of a CNP (460 Kb). 5 In addition, numerous smaller intervals of copy number difference were detected, most of which are likely to be normal CNPs. With the exception of one rare CNP observed in Patient 1, none of the smaller intervals was investigated further.
Patient 1
The cytogenetically visible interstitial deletion of 13q was revealed to consist of two noncontiguous deleted segments. The first region (221 probes) extended from 53,075,360 to (Fig. 3) . No deletion or amplification was detected at either of the breakpoint regions of the balanced translocation at 3q23 or 10q11.2. A map of the 13q deletion interval is shown in Fig. 4 . It was striking that both deleted segments occurred in gene poor regions, so that, although a total of about 10 Mb of DNA had been deleted, only six genes have been identified in the deleted region. Table 1 lists these genes, with what is known of their function. There were another 16 intervals of altered copy number ranging in size from 130 kb to 1.7 Mb, which is consistent with a "normal" degree of largescale copy number variation. One such variant was a duplication that included exon1 of the PARKIN gene at chromosome 6q26 (162,549,892 to 162,723,034 bp). Because partial alterations in dosage of PARKIN have been associated with neurological disease, this lesion was further investigated by FISH.
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Patient 2
ROMA detected a large deletion of chromosome 4 (427 probes, 58.8 to 81.9 Mb). Thus, the deletion was approximately 23 Mb in length (Fig. 5) , although it had been missed at the time of prenatal diagnosis.
Patient 3
ROMA detected a deletion of 22q, extending from approximately 43 Mb to the telomere, and a duplication of 16q extending from 82 Mb to the telomere. The deletion thus includes about 6 Mb of 22q and the duplication extends through about 8 Mb (Fig. 6) .
Confirmation of ROMA using FISH Table 2 and Figs. 7, 8, 9 show the results of the FISH experiments in Patient 1. They confirmed the noncontiguous nature of the 13q deletion, as well as the amplification in 6q in the proband. The parents both showed a normal pattern for the chromosome 13 probes. The mother, but not the father, also showed the same amplification on 6q that was found in the proband.
DISCUSSION
For Patient 2, the ROMA analysis confirmed that the breakpoints were correctly assigned by conventional cytogenetics. There had been concern as to whether the deletion might involve the KIT oncogene at 4q12. ROMA analysis showed that the proximal breakpoint at 58.8 Mb was distal to the KIT gene at 55.5 Mb. The sodium bicarbonate cotransporter, SLC4A4, is contained within the patient's deletion and is likely responsible for his proximal renal tubular acidosis. 6 Also deleted are the CXCL 1, 2, 3, 5, 6, 9, 10, and 11 members of the chemokine family of cytokines, which may be responsible for his recurrent infections. The deleted interval does not contain any genes known to be involved in glucose metabolism that might explain his recurrent hypoglycemia.
For Patient 3, ROMA analysis demonstrated that, even though the imbalance could be detected only by FISH with subtelomeric probes, the deleted and amplified chromosomal segments were both Ͼ 5 Mb and occurred in gene-rich regions. This case exemplifies the fact that terminal rearrangements detected by subtelomeric FISH may involve fairly large chromosomal segments not distinguishable by G-banding and do not necessarily involve only the most terminal regions. Application of ROMA to other "subtelomeric rearrangements" could allow the identification of "hotspots" for such exchanges and improve the ability to define new clinical syndromes.
For Patient 1, the ROMA analysis was extremely informative, revealing previously unknown complexity of the deletion and providing an explanation for the minimal clinical abnormalities found in this patient. Interstitial deletions of chromosome 13 involving bands q14.3 to q21 have been previously reported and often have a relatively mild phenotype, involving mild to moderate mental retardation, variable minor anomalies, and growth retardation. 7, 8 One familial deletion of only q21 is reported 9 in a mother and daughter who were described as completely normal. The authors, in 1985, suggested that this might be a gene-poor region based on the Giemsa banding and replication pattern, which suggested it was mostly heterochromatin.
Dean et al. 10 reviewed five cases in which a deletion of chromosome 13 was described to include band q21 and all or most of q22. All of these cases presented with mental retardation that was sometimes severe, delayed language acquisition, postnatal growth retardation, short hands, low set or posteriorly rotated ears, and a broad nasal bridge. Two patients had swallowing difficulties in early life similar to our patient. It is likely that the more severe phenotype in these cases is due to the deletion in band q22.
In our case, the parents had been advised that their child would likely have developmental delay, based on the discovery of a cytogenetically visible chromosome 13 deletion in a 3-month-old child who was hypotonic and growth retarded. The possible significance of the de novo balanced translocation was also discussed with the family. However, at the age of 3 years, his development is almost completely normal except for some delay in gross motor skills. Height and weight are at the 25th percentile, and there are no dysmorphic features except for cupped ears.
The complete DNA sequence and analysis of human chromosome 13 has recently been published. 11 Of note in this chromosome is the low gene density, especially in two central regions from 52.9 to 90.7 Mb, corresponding to bands q21 and q31. The ROMA scan provides an explanation for why our patient with a deletion of approximately 10 Mb is mildly affected. The two deletions in our patient (53 to 61.4 Mb and from 72.8 to 74.8 Mb) occur in a "gene desert" on chromosome 13; the first deletion includes a 3-Mb region with no known genes. Only six genes have been identified in the region deleted in our patient. Deletions or mutations of these genes have not been reported and therefore it is not possible to correlate any 
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predicted deleterious effects of the deletion with the phenotype of the present case. Although the deletion in chromosome 13 had been shown not to include the RB1 gene by FISH, the parents had been told that it was possible that a breakpoint close to the gene might affect its function and had been advised to undergo biannual examination for retinoblastoma and osteosarcoma. The ROMA analysis determined that the deletion began at least 8 Mb downstream of RB, making it highly unlikely to affect the function of this gene. The ROMA scan also detected no deletions or amplifications at the site of the translocation breakpoints in chromosomes 3q23 and 10q11.2. However, this does not preclude a breakpoint that interrupts a gene or interferes with gene expression.
The discovery of a noncontiguous deletion was a surprise, although we will not know how often this may occur until many more cases of interstitial deletions are examined with similar methods. Yu et al. 12 report a noncontiguous deletion in a derivative chromosome, der(1)t(1;1)(p36;q44) (their Case 9), identified by microarray CGH. One explanation for this phenomenon would be an inversion in a parental chromosome, which would bring the noncontiguous deleted segments in juxtaposition before the deletion occurred. The presence of an inversion might even predispose to deletion at meiosis in an inversion heterozygote. Another explanation would be an error in the public database. In our case, FISH analysis confirmed the order of the BAC probes and did not demonstrate any inversion in the parental chromosomes involving the deleted segments of chromosome 13. However, such an inversion may still have been present in a parental germ cell.
PARKIN mutations and deletions have been described in patients with early-onset Parkinson disease, 13, 14 and there are also two reported cases of Parkinson disease with heterozygous duplications of exon 4. 15 However, the presence of the PAR- KIN duplication at 6q26 in both the child and the normal mother suggests that this change may not be relevant to the phenotype of Patient 1. Because analysis using the 85K BglII II ROMA chip detects an average of 11 normal CNPs between unrelated individuals, 5 most of the smaller-sized copy number differences detected by ROMA will be structural polymorphisms present in the human population. Knowledge of normal copy number polymorphisms will be essential for interpretation of genomic microarray data in clinical studies. These cases illustrate the detailed information on cytogenetic abnormalities that is possible using the ROMA methodology. This method has major advantages over BAC microarray systems: resolution at least 3-fold higher than even a complete BAC tiling path; higher signal to noise ratio, due to the reduced complexity of the DNA and the lack of repetitive DNA in the small target oligonucleotides; flexible chip design; and the powerful method of statistical analysis to detect meaningful changes. 16 At the present time, costs and limited availability limit the application of this technique. New technical innovations under development will reduce costs and make ROMA more widely available. It is likely that the future of cytogenetic analysis will routinely involve the ability to define chromosomal aberrations at this "ultra" high level of resolution. Together with the information from the human genome sequence, this should immensely improve our ability both to understand the mechanisms of chromosomal rearrangements and to provide more accurate prognosis both prenatally and postnatally to parents of offspring with chromosomal aberrations. 
